EMERGENT Financial Statements From 2010 to 2024
| ER4 Stock | EUR 9.49 0.01 0.11% |
Check EMERGENT BIOSOLUT financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EMERGENT BIOSOLUT's main balance sheet or income statement drivers, such as , as well as many indicators such as . EMERGENT financial statements analysis is a perfect complement when working with EMERGENT BIOSOLUT Valuation or Volatility modules.
EMERGENT |
EMERGENT BIOSOLUT Company Revenue Analysis
EMERGENT BIOSOLUT's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current EMERGENT BIOSOLUT Revenue | 1.12 B |
Most of EMERGENT BIOSOLUT's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EMERGENT BIOSOLUT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, EMERGENT BIOSOLUT reported 1.12 B of revenue. This is much higher than that of the sector and significantly higher than that of the Other industry. The revenue for all Germany stocks is notably lower than that of the firm.
EMERGENT BIOSOLUT Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EMERGENT BIOSOLUT's current stock value. Our valuation model uses many indicators to compare EMERGENT BIOSOLUT value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EMERGENT BIOSOLUT competition to find correlations between indicators driving EMERGENT BIOSOLUT's intrinsic value. More Info.EMERGENT BIOSOLUT is rated # 2 in current valuation category among its peers. It is rated # 5 in price to book category among its peers . The ratio of Current Valuation to Price To Book for EMERGENT BIOSOLUT is about 3,145,353,769 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EMERGENT BIOSOLUT's earnings, one of the primary drivers of an investment's value.About EMERGENT BIOSOLUT Financial Statements
EMERGENT BIOSOLUT stakeholders use historical fundamental indicators, such as EMERGENT BIOSOLUT's revenue or net income, to determine how well the company is positioned to perform in the future. Although EMERGENT BIOSOLUT investors may analyze each financial statement separately, they are all interrelated. For example, changes in EMERGENT BIOSOLUT's assets and liabilities are reflected in the revenues and expenses on EMERGENT BIOSOLUT's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in EMERGENT BIOSOLUT. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in EMERGENT Stock
EMERGENT BIOSOLUT financial ratios help investors to determine whether EMERGENT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EMERGENT with respect to the benefits of owning EMERGENT BIOSOLUT security.